home / stock / nnvc / nnvc short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 17,357 |
Total Actual Volume | 797,163 |
Short Trends | |
---|---|
Cover Days | 15 |
Short Days | 4 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 868 |
Average Short Percentage | 28.31% |
Is there a NNVC Short Squeeze or Breakout about to happen?
See the NNVC Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-06-23 | 2.09 | 2.11 | 2.15 | 2.0501 | 11,067 | 215 | 82.0611 |
2022-06-22 | 2.26 | 2.15 | 2.26 | 2.09 | 36,082 | 584 | 6.8026 |
2022-06-21 | 2.01 | 2.2 | 2.23 | 2.01 | 48,736 | 347 | 4.8315 |
2022-06-17 | 1.89 | 2.01 | 2.02 | 1.89 | 15,175 | 11 | 2.7919 |
2022-06-16 | 1.96 | 1.97 | 2.02 | 1.92 | 19,326 | 290 | 35.7583 |
2022-06-15 | 1.99 | 2.01 | 2.03 | 1.9 | 25,324 | 143 | 31.3596 |
2022-06-14 | 1.79 | 1.87 | 1.92 | 1.79 | 29,688 | 842 | 31.2430 |
2022-06-13 | 1.93 | 1.92 | 1.98 | 1.8727 | 23,034 | 15 | 3.2967 |
2022-06-10 | 1.9908 | 2.02 | 2.0699 | 1.9809 | 18,667 | 508 | 17.4211 |
2022-06-09 | 2.03 | 2.08 | 2.08 | 2 | 24,192 | 62 | 4.9285 |
2022-06-08 | 1.99 | 2.05 | 2.06 | 1.8801 | 32,954 | 135 | 1.7294 |
2022-06-07 | 2 | 1.97 | 2.02 | 1.91 | 28,726 | 1,795 | 81.7023 |
2022-06-06 | 2.01 | 2.03 | 2.03 | 1.96 | 25,885 | 2,068 | 84.1677 |
2022-06-03 | 1.96 | 2 | 2.01 | 1.925 | 12,176 | 321 | 18.0438 |
2022-06-02 | 1.88 | 1.92 | 1.97 | 1.88 | 21,911 | 21 | 18.5841 |
2022-06-01 | 2 | 1.94 | 2.0396 | 1.83 | 114,384 | 7,271 | 85.3003 |
2022-05-31 | 2.1 | 2 | 2.18 | 1.96 | 48,140 | 614 | 24.4038 |
2022-05-27 | 2.25 | 2.15 | 2.25 | 2.09 | 115,404 | 1,526 | 22.0202 |
2022-05-26 | 1.97 | 2.07 | 2.2 | 1.93 | 74,694 | 449 | 6.5962 |
2022-05-25 | 1.99 | 2 | 2.05 | 1.95 | 71,598 | 140 | 3.1153 |
News, Short Squeeze, Breakout and More Instantly...
SHELTON, CT / ACCESSWIRE / May 17, 2022 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, has filed the quarterly report for third quarter of its 2022 fiscal year wi...
SHELTON, CT / ACCESSWIRE / May 16, 2022 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform reports that it has begun drug development to combat recent cases of severe ...
SHELTON, CT / ACCESSWIRE / April 25, 2022 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform is providing an update on its clinical-trial ready Coronavirus Oral and In...